Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
Saudi Arabia · Delayed Price · Currency is SAR 34.56
+0.10 (0.29%)
At close: Feb 11, 2026
TADAWUL:4017 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3,034 | 2,791 | 2,327 | 2,012 | 1,965 | 1,715 | |
Revenue Growth (YoY) | 11.93% | 19.95% | 15.62% | 2.43% | 14.53% | 4.57% |
Cost of Revenue | 2,335 | 2,092 | 1,710 | 1,412 | 1,327 | 1,199 |
Gross Profit | 698.76 | 699.04 | 616.68 | 600.35 | 637.82 | 516.51 |
Selling, General & Admin | 381.68 | 337.69 | 292.49 | 177.23 | 173.35 | 198.82 |
Amortization of Goodwill & Intangibles | - | - | - | 1.74 | 1.77 | 1.17 |
Other Operating Expenses | -11.45 | -11.19 | -21.14 | -12.36 | - | - |
Operating Expenses | 393.81 | 339.98 | 282.7 | 218.3 | 261.4 | 236.43 |
Operating Income | 304.95 | 359.06 | 333.98 | 382.05 | 376.41 | 280.08 |
Interest Expense | -43.17 | -95.67 | -122.15 | -55.94 | -34.79 | -46.16 |
Interest & Investment Income | 25.72 | 23.67 | 42.88 | 24.88 | 6.17 | 8.49 |
Other Non Operating Income (Expenses) | - | - | - | - | 17.55 | 9.08 |
EBT Excluding Unusual Items | 287.51 | 287.07 | 254.71 | 351 | 365.34 | 251.49 |
Gain (Loss) on Sale of Assets | - | - | - | 0.13 | - | - |
Pretax Income | 287.51 | 287.07 | 254.71 | 351.12 | 365.34 | 251.49 |
Income Tax Expense | 26.49 | 23.4 | 22.69 | 20.44 | 4.56 | 26.65 |
Earnings From Continuing Operations | 261.02 | 263.67 | 232.02 | 330.68 | 360.78 | 224.84 |
Minority Interest in Earnings | 38.72 | 23.88 | 47.58 | -4.37 | -26.5 | -21.66 |
Net Income | 299.74 | 287.55 | 279.6 | 326.32 | 334.28 | 203.18 |
Net Income to Common | 299.74 | 287.55 | 279.6 | 326.32 | 334.28 | 203.18 |
Net Income Growth | 4.16% | 2.85% | -14.32% | -2.38% | 64.53% | -32.60% |
Shares Outstanding (Basic) | 230 | 217 | 200 | 200 | 100 | 100 |
Shares Outstanding (Diluted) | 230 | 217 | 200 | 200 | 100 | 100 |
Shares Change (YoY) | 9.68% | 8.59% | - | 100.00% | - | - |
EPS (Basic) | 1.30 | 1.32 | 1.40 | 1.63 | 3.34 | 2.03 |
EPS (Diluted) | 1.30 | 1.32 | 1.40 | 1.63 | 3.34 | 2.03 |
EPS Growth | -5.04% | -5.29% | -14.32% | -51.19% | 64.53% | - |
Free Cash Flow | -140.69 | -43.7 | 32.31 | -138.23 | 174.63 | -60.07 |
Free Cash Flow Per Share | -0.61 | -0.20 | 0.16 | -0.69 | 1.75 | -0.60 |
Dividend Per Share | 0.300 | 0.300 | - | - | - | - |
Gross Margin | 23.03% | 25.05% | 26.50% | 29.83% | 32.46% | 30.11% |
Operating Margin | 10.05% | 12.87% | 14.35% | 18.98% | 19.16% | 16.33% |
Profit Margin | 9.88% | 10.30% | 12.02% | 16.21% | 17.02% | 11.84% |
Free Cash Flow Margin | -4.64% | -1.57% | 1.39% | -6.87% | 8.89% | -3.50% |
EBITDA | 420.66 | 460.52 | 428.55 | 451.31 | 437.29 | 339.26 |
EBITDA Margin | 13.87% | 16.50% | 18.42% | 22.43% | 22.26% | 19.78% |
D&A For EBITDA | 115.71 | 101.45 | 94.57 | 69.26 | 60.88 | 59.17 |
EBIT | 304.95 | 359.06 | 333.98 | 382.05 | 376.41 | 280.08 |
EBIT Margin | 10.05% | 12.87% | 14.35% | 18.98% | 19.16% | 16.33% |
Effective Tax Rate | 9.21% | 8.15% | 8.91% | 5.82% | 1.25% | 10.60% |
Advertising Expenses | - | 26.29 | 31.72 | 5.74 | 11.66 | 6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.